Odonate Therapeutics, Inc. ODT
1.12 +1.12
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 4.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 2
- 2 months ago 2
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.93 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.83 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2019 | Empire Asset Management | Initiated | — | Sell |
| Jan 2, 2018 | Goldman Sachs | Initiated | — | Neutral |
| Jan 2, 2018 | Jefferies | Initiated | — | Buy |
| Jan 2, 2018 | Cowen & Co. | Initiated | — | Outperform |